WHO-GMP Certified Commercial Pack · Product Code: AKP-024
Diclofenac 1.0%, Linseed Oil 3.0%, Methyl Salicylate 10%, Menthol 5.0% & Benzyl Alcohol 1.0% Gel
Formulation Overview: Rapid-penetration transdermal rubefacient pain-relief gel combining deep NSAID prostaglandin suppression with cooling menthol and warming methyl salicylate vasodilation. Formulated with Diclofenac Diethylamine (eq. Diclofenac 1.0%) + Linseed Oil 3.0% + Methyl Salicylate 10.0% + Menthol 5.0% + Benzyl Alcohol 1.0% (1.0% / 3.0% / 10% / 5.0% / 1.0% w/w) in Topical Analgesic Gel dosage form under Pain, Inflammation & NSAIDs, manufactured to IP / BP / USP Compendial standards and supplied in 30g Laminated Collapsible Tube with Flip-Cap & Carton with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-024 |
|---|---|
| Therapeutic Sector | Pain, Inflammation & NSAIDs |
| Dosage Form | Topical Analgesic Gel |
| Active Ingredient | Diclofenac Diethylamine (eq. Diclofenac 1.0%) + Linseed Oil 3.0% + Methyl Salicylate 10.0% + Menthol 5.0% + Benzyl Alcohol 1.0% |
| Strength / Purity | 1.0% / 3.0% / 10% / 5.0% / 1.0% w/w |
| Clinical Indication | Sprains, strains, osteoarthritis knee pain, myofascial spasm, and sports soft-tissue injuries |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 30g Laminated Collapsible Tube with Flip-Cap & Carton |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; keep away from heat and open flame |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |